FibroGen Inc
(MEX:FGEN)
MXN
20.13
0 (0%)
Market Cap: 2.05 Bil
Enterprise Value: 1.54 Bil
PE Ratio: 0
PB Ratio: 0
GF Score: 46/100 - Q1 2024 FibroGen Inc Earnings Call TranscriptMay 06, 2024MXN20.25 (-6.98%)Earnings
- Q4 2023 FibroGen Inc Earnings Call TranscriptFeb 26, 2024MXN30 (-20.09%)Earnings
- FibroGen Inc KOL Investor Event Series Part I (Virtual) TranscriptFeb 13, 2024
- Q3 2023 FibroGen Inc Earnings Call TranscriptNov 06, 2023MXN15.08Earnings
- Q2 2023 FibroGen Inc Earnings Call TranscriptAug 07, 2023MXN31 (-90.91%)Earnings
- FibroGen Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- FibroGen Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Q1 2023 FibroGen Inc Earnings Call TranscriptMay 08, 2023MXN341.2Earnings
- Q4 2022 FibroGen Inc Earnings Call TranscriptFeb 27, 2023MXN461.5Earnings
- FibroGen Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 08, 2022
- Q3 2022 FibroGen Inc Earnings Call TranscriptNov 07, 2022MXN350.5Earnings
- Q2 2022 FibroGen Inc Earnings Call TranscriptAug 08, 2022MXN251Earnings
- Q1 2022 FibroGen Inc Earnings Call TranscriptMay 09, 2022MXN257.5Earnings
- Q4 2021 FibroGen Inc Earnings Call TranscriptFeb 28, 2022MXN314Earnings
- Q3 2021 FibroGen Inc Earnings Call TranscriptNov 09, 2021MXN246 (-8.21%)Earnings
- Q2 2021 FibroGen Inc Earnings Call TranscriptAug 09, 2021MXN278 (+0.36%)Earnings
- FibroGen Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- FibroGen Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 04, 2021
- FibroGen Inc Annual Shareholders Meeting TranscriptMay 26, 2021
- FibroGen Inc at Bank of America Global Research Healthcare Conference (Virtual) - Fireside Chat TranscriptMay 13, 2021
- Q1 2021 FibroGen Inc Earnings Call TranscriptMay 10, 2021MXN386.14 (-6.25%)Earnings
- FibroGen Inc Provides Additional Information on Roxadustat - Conference Call TranscriptApr 06, 2021
- FibroGen Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 02, 2021
- Q4 2020 FibroGen Inc Earnings Call TranscriptMar 01, 2021MXN1037Earnings
- FibroGen Inc at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 25, 2021
- FibroGen Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 19, 2020
- Q3 2020 FibroGen Inc Earnings Call TranscriptNov 05, 2020MXN1012Earnings
- FibroGen Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- FibroGen Inc at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2020
- Q2 2020 FibroGen Inc Earnings Call TranscriptAug 06, 2020MXN987Earnings
- FibroGen Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2020
- FibroGen Inc Annual Shareholders Meeting TranscriptJun 04, 2020
- FibroGen Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2020
- FibroGen Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Q1 2020 FibroGen Inc Earnings Call TranscriptMay 07, 2020MXN900Earnings
- Q4 2019 FibroGen Inc Earnings Call TranscriptMar 02, 2020MXN800 (-2.91%)Earnings
- FibroGen Inc at Leerink Global Healthcare Conference TranscriptFeb 25, 2020
- Q3 2019 FibroGen Inc Earnings Call TranscriptNov 11, 2019MXN645Earnings
- Q2 2019 FibroGen Inc Earnings Call TranscriptAug 08, 2019MXN740Earnings
- FibroGen Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 12, 2019
- Q1 2019 FibroGen Inc Earnings Call TranscriptMay 09, 2019MXN890Earnings
- Q4 2018 FibroGen Inc Earnings Call TranscriptFeb 27, 2019MXN865Earnings
FibroGen Inc at Cowen Healthcare Conference (Virtual) Transcript
Mar 02, 2021 / 05:50PM GMT
Release Date Price:
MXN776
(-25.17%)
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
And good afternoon, everybody, and thank you for joining us for the second day of the 41st Annual Cowen Healthcare Conference. I'm Yaron Werber, biotech analyst here at Cowen with my colleague, Brendan Smith. And it's a great pleasure for us to moderate the fireside chat with FibroGen.
Today, we have Enrique Conterno, who's the CEO; and Mike Tung, VP of Investor Relations and Strategy. Gentlemen, thanks so much for joining us. We appreciate it.
Enrique A. Conterno
FibroGen, Inc. - CEO & Director
Thank you very much for the invitation, Yaron.
Questions & Answers
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
Absolutely. So Enrique, maybe the timing for this is good in a way, just given some of the news from yesterday, obviously, wasn't prepped that way by chance. But maybe give us a little bit of a sense related to the news flow
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)